T1	chemical 0 11	Sibutramine
T2	chemical 31 35	drug
T3	disease_or_phenotypic_feature 62 69	obesity
T4	chemical 109 118	inhibitor
T5	chemical 120 129	celecoxib
T6	chemical 134 143	cisplatin
T7	disease_or_phenotypic_feature 152 163	lung tumors
T8	disease_or_phenotypic_feature 174 186	hypocalcemia
T9	disease_or_phenotypic_feature 187 201	hypomagnesemia
T10	disease_or_phenotypic_feature 203 220	hyperphosphatemia
T11	chemical 234 243	phosphate
T12	chemical 302 314	moxifloxacin
T13	chemical 331 339	solution
T14	disease_or_phenotypic_feature 343 351	cataract
T15	chemical 371 381	Anesthesia
T16	disease_or_phenotypic_feature 396 408	cleft palate
T17	chemical 432 436	food
T18	disease_or_phenotypic_feature 453 460	obesity
T19	disease_or_phenotypic_feature 487 494	obesity
T20	chemical 557 566	inhibitor
T21	chemical 567 578	roflumilast
T22	disease_or_phenotypic_feature 580 588	Diplopia
T23	disease_or_phenotypic_feature 595 603	cataract
T24	chemical 669 679	anesthesia
T25	chemical 730 740	anesthesia
T26	disease_or_phenotypic_feature 745 753	cataract
T27	chemical 763 774	mepivacaine
T28	chemical 784 793	lidocaine
T29	chemical 794 805	bupivacaine
T30	chemical 806 813	mixture
T31	chemical 840 850	inhibitors
T32	disease_or_phenotypic_feature 860 868	cataract
T33	chemical 878 895	Food antioxidants
T34	disease_or_phenotypic_feature 907 915	cataract
T35	disease_or_phenotypic_feature 927 945	skeletal dysplasia
T36	disease_or_phenotypic_feature 946 964	mental retardation
T37	disease_or_phenotypic_feature 965 973	syndrome
T38	disease_or_phenotypic_feature 979 992	abnormal face
T39	chemical 999 1008	uric acid
T40	disease_or_phenotypic_feature 1009 1028	metabolism disorder
T41	chemical 1081 1089	Bombesin
T42	chemical 1094 1105	antagonists
T43	disease_or_phenotypic_feature 1110 1125	prostate cancer
T44	disease_or_phenotypic_feature 1153 1166	Heart failure
T45	chemical 1168 1177	oxidative
T46	chemical 1189 1200	allopurinol
T47	chemical 1202 1216	Growth hormone
T48	disease_or_phenotypic_feature 1245 1252	obesity
T49	disease_or_phenotypic_feature 1344 1357	hydrocephalus
T50	disease_or_phenotypic_feature 1383 1400	cerebral ischemia
T51	disease_or_phenotypic_feature 1414 1422	seizures
T52	chemical 1498 1504	sodium
T53	chemical 1506 1511	water
T54	chemical 1517 1524	glucose
T55	disease_or_phenotypic_feature 1526 1546	Rheumatoid arthritis
T56	chemical 1562 1572	infliximab
T57	chemical 1598 1607	inhibitor
T58	chemical 1627 1631	food
T59	disease_or_phenotypic_feature 1655 1662	obesity
T60	disease_or_phenotypic_feature 1664 1679	Agranulocytosis
T61	disease_or_phenotypic_feature 1684 1693	hepatitis
T62	chemical 1717 1721	drug
T63	disease_or_phenotypic_feature 1771 1778	obesity
T64	chemical 1794 1802	agonists
T65	chemical 1812 1816	food
T66	disease_or_phenotypic_feature 1845 1852	obesity
R1	treats Arg1:T1 Arg2:T3	
T67	corrected_chemical 103 118	COX-2 inhibitor
R2	treats Arg1:T21 Arg2:T19	
T68	corrected_chemical 532 566	phosphodiesterase type-4 inhibitor
R3	treats Arg1:T68 Arg2:T19	
R4	treats Arg1:T33 Arg2:T34	
T69	corrected_disease_or_phenotypic_feature 917 973	Hirsutism-skeletal dysplasia-mental retardation syndrome
R5	causes_or_contributes_to Arg1:T39 Arg2:T69	
R7	causes_or_contributes_to Arg1:T56 Arg2:T55	
R8	causes_or_contributes_to Arg1:T58 Arg2:T59	
T70	DONE 1854 1858	DONE
